Power of compounding intravitreal Bevacizumab - Experience from a tertiary eye care hospital

Background: Bevacizumab vials that are commercially available are fractionated into smaller quantities into the form of pre-filled syringes in a sterile and aseptic laboratory setting. Purpose: To share the long term experience of aliquoting of bevacizumab injections in a tertiary eye care center in...

Full description

Bibliographic Details
Main Authors: Santosh Ramesh, S Sivaranjani, Nirav Zala Hasmukhbhai, Divya Yadav
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Indian Journal of Ophthalmology
Subjects:
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2022;volume=70;issue=5;spage=1869;epage=1869;aulast=Ramesh;type=0
_version_ 1818161217962770432
author Santosh Ramesh
S Sivaranjani
Nirav Zala Hasmukhbhai
Divya Yadav
author_facet Santosh Ramesh
S Sivaranjani
Nirav Zala Hasmukhbhai
Divya Yadav
author_sort Santosh Ramesh
collection DOAJ
description Background: Bevacizumab vials that are commercially available are fractionated into smaller quantities into the form of pre-filled syringes in a sterile and aseptic laboratory setting. Purpose: To share the long term experience of aliquoting of bevacizumab injections in a tertiary eye care center in India. Synopsis: Compounding of bevacizumab was found to be a cost-effective and sustainable practice that has benefited more patients with an affordable cost, while maintaining high levels of quality. Highlights: Compounding of bevacizumab, when done with aseptic precautions can be a safe and cost-effective practice, the benefits of which can be passed on to needful patients. Video Link: https://youtu.be/C5XOpKHFkew
first_indexed 2024-12-11T16:14:16Z
format Article
id doaj.art-33c32555cbef4c4dbee27744c12a3221
institution Directory Open Access Journal
issn 0301-4738
1998-3689
language English
last_indexed 2024-12-11T16:14:16Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Ophthalmology
spelling doaj.art-33c32555cbef4c4dbee27744c12a32212022-12-22T00:58:59ZengWolters Kluwer Medknow PublicationsIndian Journal of Ophthalmology0301-47381998-36892022-01-017051869186910.4103/ijo.IJO_1016_22Power of compounding intravitreal Bevacizumab - Experience from a tertiary eye care hospitalSantosh RameshS SivaranjaniNirav Zala HasmukhbhaiDivya YadavBackground: Bevacizumab vials that are commercially available are fractionated into smaller quantities into the form of pre-filled syringes in a sterile and aseptic laboratory setting. Purpose: To share the long term experience of aliquoting of bevacizumab injections in a tertiary eye care center in India. Synopsis: Compounding of bevacizumab was found to be a cost-effective and sustainable practice that has benefited more patients with an affordable cost, while maintaining high levels of quality. Highlights: Compounding of bevacizumab, when done with aseptic precautions can be a safe and cost-effective practice, the benefits of which can be passed on to needful patients. Video Link: https://youtu.be/C5XOpKHFkewhttp://www.ijo.in/article.asp?issn=0301-4738;year=2022;volume=70;issue=5;spage=1869;epage=1869;aulast=Ramesh;type=0intravitreal injectioncompoundingbevacizumab
spellingShingle Santosh Ramesh
S Sivaranjani
Nirav Zala Hasmukhbhai
Divya Yadav
Power of compounding intravitreal Bevacizumab - Experience from a tertiary eye care hospital
Indian Journal of Ophthalmology
intravitreal injection
compounding
bevacizumab
title Power of compounding intravitreal Bevacizumab - Experience from a tertiary eye care hospital
title_full Power of compounding intravitreal Bevacizumab - Experience from a tertiary eye care hospital
title_fullStr Power of compounding intravitreal Bevacizumab - Experience from a tertiary eye care hospital
title_full_unstemmed Power of compounding intravitreal Bevacizumab - Experience from a tertiary eye care hospital
title_short Power of compounding intravitreal Bevacizumab - Experience from a tertiary eye care hospital
title_sort power of compounding intravitreal bevacizumab experience from a tertiary eye care hospital
topic intravitreal injection
compounding
bevacizumab
url http://www.ijo.in/article.asp?issn=0301-4738;year=2022;volume=70;issue=5;spage=1869;epage=1869;aulast=Ramesh;type=0
work_keys_str_mv AT santoshramesh powerofcompoundingintravitrealbevacizumabexperiencefromatertiaryeyecarehospital
AT ssivaranjani powerofcompoundingintravitrealbevacizumabexperiencefromatertiaryeyecarehospital
AT niravzalahasmukhbhai powerofcompoundingintravitrealbevacizumabexperiencefromatertiaryeyecarehospital
AT divyayadav powerofcompoundingintravitrealbevacizumabexperiencefromatertiaryeyecarehospital